Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Lyell Immunopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LYEL.
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Other companies in Lyell Immunopharma’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), 4D Molecular Therapeutics (NASDAQ:FDMT), Quoin Pharmaceuticals (NASDAQ:QNRX) and Korro Bio (NASDAQ:KRRO).
Lyell Immunopharma has a consensus price target of $2.75.
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $0.4377 last updated April 21, 2025 at 4:02 PM EDT.
There are no upcoming dividends for Lyell Immunopharma.
Lyell Immunopharma’s Q1 earnings are confirmed for Monday, May 5, 2025.
There is no upcoming split for Lyell Immunopharma.
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.